razoxane has been researched along with Allergy, Drug in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, T; Hamatake, M; Ishida, R; Nitiss, JL; Wang, JC; Wasserman, RA | 1 |
1 other study(ies) available for razoxane and Allergy, Drug
| Article | Year |
|---|---|
DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.
Topics: Amsacrine; Antineoplastic Agents; Diketopiperazines; DNA Topoisomerases, Type II; Drug Hypersensitivity; Drug Resistance; Piperazines; Razoxane; Saccharomyces cerevisiae; Topoisomerase II Inhibitors | 1995 |